NEW: Express access to COVID-19 vaccine record is now available.

The MyHealth.Alberta.ca Network showcases trusted, easy-to-use health and wellness resources from Alberta Health Services and Alberta-based partner organizations. The network is led by MyHealth.Alberta.ca, Alberta’s source for consumer health information. Our partners are committed to helping Albertans better manage their health and wellbeing. Health experts across Alberta make sure that the information on these sites is accurate and up-to-date. Our partners include

MyHealth.Alberta.ca Network
Health Information and Tools > Medications >  Inotersen - Subcutaneous Injection

Main Content

Inotersen - Subcutaneous Injection

Pronunciation: IN-oh-TER-sen

Common Brand Name(s): Tegsedi

Important: How To Use This Information

This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Warning

This medication decreases the number of platelets in your blood, which may cause serious (even fatal) bleeding problems. Tell your doctor right away if you notice symptoms such as easy bruising, a rash of tiny reddish-purple spots (especially on your lower legs), bleeding gums, nosebleeds, blood in urine/stools, vomiting or coughing up blood, neck stiffness, unusual severe headache, or unusual/heavy menstrual periods (women).

This medication can cause serious kidney damage that may result in the need for dialysis. Tell your doctor right away if you have swelling in your face/feet/hands, shortness of breath, cough, blood in urine, brown/foamy urine, or change in amount of urine.

Careful monitoring and treatment by your doctor may decrease your risk for serious side effects. Lab and/or medical tests (such as kidney/liver function, complete blood count, urine tests) should be done before you start using this medication, while you are using it, and for 8 weeks after stopping treatment. Keep all medical and lab appointments.

To receive this medication in the United States, you must understand, agree to, and carefully follow the requirements of the Tegsedi REMS Program. If you live in Canada or any other country, consult your doctor and pharmacist for your country's regulations.

Information about Inotersen - Subcutaneous Injection

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Information about Inotersen - Subcutaneous Injection